Pharmacovigilance – News and Features

News
Osiris Recieves FDA Fast Track status and Clearance to Start Phase III trials for Crohn’s Disease Stem Cell Therapy
Company’s Phase III program will be the last phase of testing before it seeks full approval for Crohn’s Disease.

News
Caliper Life Sciences Launches Drug Discovery and Development Services Business
Caliper combines in vitro and in vivo services of Novascreen Biosciences and Xenogen Biosciences to form Discovery Alliances & Services.

News
New Report Finds Little Evidence to Determine the Usefulness of Genetic Tests in the Treatment of Depression
This evidence report is the first step in the two-step process of the Centers for Disease Control and Prevention's Evaluation of Genomic Applications in Practice and Prevention pilot project.

News
Iongate Leads Collaboration to Develop Tools to Predict and Evaluate Undesirable Side Effects in Pharmaceuticals
The project lead by Iongate involves quantitative analysis that can facilitate the description of dynamic processes in living systems.

News
Launch of New Center for Proteomics and Drug Actions
Vanderbilt University Medical Center and the National Foundation for Cancer Research have established a cancer research center from $1 million funded by NFCR.

News
Key Immune Cells Predict Recurrence in Lung Cancer Patients
Researchers found that the more T-regulatory cells and the fewer T-cell lymphocytes present in the tumors of treated patients, the greater the likelihood the cancer would recur.

News
Genedata Expands High Content Screening Collaboration with Serono
Serono will use Genedata’s computational solution to combine results from HCS assays with chemical and pharmacological information to identify promising drug candidates.

News
NIH Selects Purdue to use phi29 DNA Packaging Motor for National Nanomedicine Development Center
A multidisciplinary Purdue research team will lead one of eight national nanomedicine development centers.

News
ReNeuron Announces Filing IND Application to the FDA for ReN001
ReNeuron files IND application to commence human clinical studies with ReN001 stem cell therapy for stroke.

News
InnoMed’s Drug Safety Database Goes Live
InnoMed PredTox is a joint industry, academic and European Commission collaboration to improve drug safety testing.
Advertisement